Sort   by:  
 Page size 
UnknownLong-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies.
Not available
S-EPMC4937081 | biostudies-literature
UnknownCharacterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes.
Not available
S-EPMC6064585 | biostudies-literature
UnknownEfficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes.
Not available
S-EPMC6220756 | biostudies-literature
UnknownA RAC-GEF network critical for early intestinal tumourigenesis.
Not available
S-EPMC7782582 | biostudies-literature
UnknownPerception of Treatment Success and Impact on Function with Antibiotics or Appendectomy for Appendicitis: A Randomized Clinical Trial with an Observational Cohort.
Not available
S-EPMC10174100 | biostudies-literature
UnknownSame data, different analysts: variation in effect sizes due to analytical decisions in ecology and evolutionary biology.
Not available
S-EPMC11804095 | biostudies-literature
Sort   by:  
 Page size